Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−8.8203 USD
−15.19 M USD
0.00 USD
7.79 M
About Virpax Pharmaceuticals, Inc.
Sector
CEO
Jatinder Dhaliwal
Headquarters
Berwyn
Website
Founded
2016
FIGI
BBG00QFP0NW4
Virpax Pharmaceuticals, Inc. is a preclinical stage biopharmaceutical company, which engages in the development of branded, non-addictive pain management products. Its products include metered-dose spray, liposomal gel encapsulates, and intranasal spray. The company was founded by Anthony P. Mack and Jeffrey A. Gudin in 2016 and and is headquartered in Berwyn, PA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of VRPX is 0.3300 USD — it has increased by 4.30% in the past 24 hours. Watch Virpax Pharmaceuticals, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Virpax Pharmaceuticals, Inc. stocks are traded under the ticker VRPX.
VRPX stock has risen by 6.45% compared to the previous week, the month change is a −53.52% fall, over the last year Virpax Pharmaceuticals, Inc. has showed a −90.57% decrease.
VRPX reached its all-time high on Aug 18, 2021 with the price of 360.0000 USD, and its all-time low was 0.2860 USD and was reached on Dec 13, 2024. View more price dynamics on VRPX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
VRPX stock is 15.51% volatile and has beta coefficient of −0.47. Track Virpax Pharmaceuticals, Inc. stock price on the chart and check out the list of the most volatile stocks — is Virpax Pharmaceuticals, Inc. there?
Today Virpax Pharmaceuticals, Inc. has the market capitalization of 2.67 M, it has increased by 9.39% over the last week.
Yes, you can track Virpax Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
Virpax Pharmaceuticals, Inc. is going to release the next earnings report on Mar 26, 2025. Keep track of upcoming events with our Earnings Calendar.
VRPX earnings for the last quarter are −0.54 USD per share, whereas the estimation was −0.54 USD resulting in a 0.00% surprise. The estimated earnings for the next quarter are −0.27 USD per share. See more details about Virpax Pharmaceuticals, Inc. earnings.
VRPX net income for the last quarter is −2.01 M USD, while the quarter before that showed −3.45 M USD of net income which accounts for 41.85% change. Track more Virpax Pharmaceuticals, Inc. financial stats to get the full picture.
No, VRPX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 7.00 employees. See our rating of the largest employees — is Virpax Pharmaceuticals, Inc. on this list?
Like other stocks, VRPX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Virpax Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Virpax Pharmaceuticals, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Virpax Pharmaceuticals, Inc. stock shows the sell signal. See more of Virpax Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.